Thus, the pro-fibrogenic effect of PCSK9 in human cardiac fibroblasts found in the current study is thought to be clinically relevant, and PCSK9 may be a potential therapeutic target for HF. The gene discussed is PCSK9; the disease is hydrops fetalis.